| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Aug―18 |
Ingavirin as a potentially effective treatment for coronavirus: An investigative study of patient outcomes |
Anahit Mkrtchyan, Hamzeh Ghorbani, Arsen Minasyan, David A. Wood, Lilit Sukiasyan, Harutyun S. Hovhannisyan, Rozi Yeremyan, Natali Minasian |
| 2 |
[GO] |
2026―Jul―22 |
Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India |
Rohit Menon, Sushil Kumar Sharma, Anshuman Behera, Ambuj Shrivastava, Shashi Sharma, Jyoti S. Kumar, Paban Kumar Dash, Manmohan Parida |
| 3 |
[GO] |
2026―May―21 |
First molecular detection and genetic characterization of feline coronavirus from India |
R. Vijayalakshmi, P. Raja, M. Parthiban, M. Chandrasekar, V. Naveenkumar, V. Vinitha, Aswathy Nair, S. Parthiban, G. Dhinakar Raj |
| 4 |
[GO] |
2025―Oct―23 |
Assessing COVID-19 IgG levels among vaccinated and non-vaccinated individuals in Mthatha - South africa: A case-control approach |
William Owusu, Gabriel Tchuente Kamsu, Eugene Jamot Ndebia |
| 5 |
[GO] |
2025―May―31 |
Influence of COVID-19 on pediatric immunocompromised children: mechanism and implications for pathogenesis |
Sheena Mariam Thomas, Ramakrishnan Veerabathiran |
| 6 |
[GO] |
2025―Mar―20 |
Abstracts of the papers presented in the international conference of Indian Virological Society, VIROCON 2024 on “Emerging viruses: pandemic and biosecurity perspectives” held during 11-13 November, 2024 at Defence Research and Development Establishment (DRDE), DRDO, Ministry of Defence, Gwalior, India |
|
| 7 |
[GO] |
2025―Jan―07 |
Seroprevalence study of the new coronavirus (SARS-CoV-2) in families and cohabitants of confirmed cases in Mashhad, Iran: a cross-sectional study |
Amir Masoud Hashemian, Nafiseh Todarbari, Manouchehr Teymouri, Vahid Hajali, Seyed Jalal Ghorbani, Ehsan Saburi |
| 8 |
[GO] |
2024―Nov―09 |
Comparison of SARS-CoV-2 RNA detection in different types of clinical specimens among suspected COVID-19 patients in Addis Ababa, Ethiopia |
Tadesse Lejisa, Rozina Ambachew, Demiraw Bikila, Chala Bashea, Abera Abdeta, Dawit Chala, Natnael Dejene, Habteyes Hailu Tola, Gadissa Bedada Hundie |
| 9 |
[GO] |
2024―Sep―30 |
Exploring immunogenic CD8 + T-cell epitopes for peptide-based vaccine development against evolving SARS-CoV-2 variants: An immunoinformatics approach |
Mohd Sultan Khan, Madhvi Shakya, Chandan Kumar Verma |
| 10 |
[GO] |
2024―Aug―09 |
Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in India |
Meghna Banerjee, Dipjyoti Chakraborty, Arindom Chakraborty |
| 11 |
[GO] |
2024―Jul―02 |
Sewage surveillance of SARS-CoV-2 in Tokyo (May 2020-June 2022): method using high-throughput, fully-automated platform |
Ryota Kumagai, Mamiyo Kawakami, Fumi Kasuya, Kinji Yamada, Akihiro Takahashi, Kouki Murayama, Kenshi Morita, Tomoya Kaneyasu, Naoko Tamai, Michiya Hasegawa, Sachiko Harada, Arisa Amano, Takushi Fujiwara, Hirofumi Miyake, Mami Nagashima, Kenji Sadamasu |
| 12 |
[GO] |
2024―Jun―07 |
SARS-CoV-2 RT-LAMP in saliva: enhancing the results via a combination of cooling and specimen dilution procedure |
Henry Gotama Putra, Sem Samuel Surja, Tria Asri Widowati, Soegianto Ali, Maria Mardalena Martini Kaisar |
| 13 |
[GO] |
2024―May―27 |
p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein |
Priyasi Mittal, Nitin Khandelwal, Yogesh Chander, Assim Verma, Ram Kumar, Chayanika Putatunda, Sanjay Barua, Baldev Raj Gulati, Naveen Kumar |
| 14 |
[GO] |
2024―May―27 |
Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection |
Mohammad Hassan Kalantar Neyestanaki, Omid Gholizadeh, Fatemeh Hosseini Tabatabaie, Sama Akbarzadeh, Saman Yasamineh, Hamed Afkhami, Somayeh Sedighi |
| 15 |
[GO] |
2024―Apr―02 |
Effect of COVID-19 pandemic on influenza; observation of a tertiary level virology laboratory |
Amita Jain, Shreya Mahesh, Om Prakash, Danish N. Khan, Anil Kumar Verma, Yashasvi Rastogi |
| 16 |
[GO] |
2023―Nov―23 |
Immunodominant conserved moieties on spike protein of SARS-CoV-2 renders virulence factor for the design of epitope-based peptide vaccines |
Subhashree Mohapatra, Santosh Kumar, Shashank Kumar, Atul Kumar Singh, Bismita Nayak |
| 17 |
[GO] |
2023―Nov―07 |
Molecular characterization of G and F protein genes of bovine respiratory syncytial virus detected from dead calves caused by severe respiratory syndrome: emergence of novel mutations and their importance |
Murat Kaplan, Emre Özan, Kemal Pekmez, Abdurrahman Anıl Çağırgan, Fatih Arslan |
| 18 |
[GO] |
2023―Oct―10 |
Clinical characteristics and predictors of COVID-19 in a community sample from urban areas of Chennai, Southern India |
Sivapriya Murugesan, Hema C. Ramamurthi, Saramma M. Jacob, Srinivas Govindarajulu |
| 19 |
[GO] |
2023―Sep―07 |
Integrated point-of-care RT-PCR methods during and after COVID-19 pandemic |
Shagun Sharma, Surabhi Shrivastava, Shankar B. Kausley, Beena Rai |
| 20 |
[GO] |
2023―Aug―10 |
Outcomes of COVID-19 in immunocompromised patients: a single center experience |
Masoud Mardani, Jafar Mohammadshahi, Roghayeh Teimourpour |
| 21 |
[GO] |
2023―May―31 |
The high mutation rate at the D614G hotspot-furin cleavage site region increases the priming efficiency of the Spike protein by furin protease: analysis of Indonesian SARS-CoV-2 G614 variants obtained during the early COVID-19 pandemic |
Faris Muhammad Gazali, Nastiti Wijayanti, Mohamad Saifudin Hakim, Endah Supriyati, Eggi Arguni, Marselinus Edwin Widyanto Daniwijaya, Titik Nuryastuti, Matin Nuhamunada, Rahma Nabilla, Sofia Mubarika Haryana, Tri Wibawa |
| 22 |
[GO] |
2023―May―11 |
Divergent mutations of Delta and Omicron variants: key players behind differential viral attributes across the COVID-19 waves |
Amrita Panja, Jayita Roy, Anup Mazumder, Sujata Maiti Choudhury |
| 23 |
[GO] |
2023―May―03 |
Multicenter study of some liver and heart function tests in SARS-Cov-2 patients from three ethnic groups in Iran |
Seyed Majid Fatahi, Hadi Razavi Nikoo, Ali Safarzadeh, Gholam Reza Talei, Sayyad Khanizadeh, Ashkan Alamdary, Rasool Mohammadi, Mehdi Ajorloo |
| 24 |
[GO] |
2023―Feb―04 |
Molecular detection and identification of fungal pathogens infections occurring in COVID-19 recovered patients |
Dhanurekha Lakshmipathy, Anand Appakudal Ramaswamy, Hema Raja Pushpam Maharajan, Revathy Menon Anand, Aishwariya Thangam, Ranjith Kumar Santharaj |
| 25 |
[GO] |
2023―Feb―02 |
An algorithm to estimate the real time secondary infections in sub-urban bus travel: COVID-19 epidemic experience at Chennai Metropolitan city India |
Ganesh Ram Arumugam, Bakiya Ambikapathy, Kamalanand Krishnamurthy, Ashwani Kumar, Lourduraj De Britto |
| 26 |
[GO] |
2022―Nov―10 |
SARS-CoV-2 variants of concerns in animals: An unmonitored rising health threat |
AbdulRahman A. Saied, Asmaa A. Metwally |
| 27 |
[GO] |
2022―Oct―25 |
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview |
Sivan Padma Priya, P. M. Sunil, Sudhir Varma, Carel Brigi, Mohammad Faruq Abd Rachman Isnadi, J. A. Jayalal, R. Arunkumar Shadamarshan, S. Suresh Kumar, Neela Vasantha Kumari, Rishi P. R. Kumar |
| 28 |
[GO] |
2022―Aug―13 |
Potential factors influencing COVID-19 vaccine acceptance and hesitancy among Bangladeshi people: a cross-sectional study |
Debendra Nath Roy, Md. Mohabbot Hossen, Nowrin Ferdiousi, Md. Shah Azam |
| 29 |
[GO] |
2022―Aug―05 |
Prediction of infectivity of SARS-CoV-2 virus based on Spike-hACE-2 interaction |
Dwaipayan Chaudhuri, Joyeeta Datta, Satyabrata Majumder, Kalyan Giri |
| 30 |
[GO] |
2022―Aug―05 |
Surface contamination by SARS-CoV2 RNA in dedicated COVID care area of a tertiary care hospital in North India |
Subhabrata Sarkar, Arnab Ghosh, Ritin Mohindra, Linta Thomas, Devender Yadav, Harish Chand Kandpal, Manisha Biswal, P. V. M. Lakshmi, Vikas Suri, Vipin Koushal, Pankaj Malhotra, R. K. Ratho, G. D. Puri, Mini P. Singh |
| 31 |
[GO] |
2022―Jul―22 |
Growth kinetics of an Indian isolate of highly pathogenic porcine reproductive and respiratory syndrome virus in MARC-145 cells |
Subbiah Kombiah, Dhanapal Senthilkumar, Manoj Kumar, Panickan Sivasankar, Vijendra P. Singh, Katherukamem Rajukumar |
| 32 |
[GO] |
2022―Jun―07 |
Seroprevalence of SARS-CoV-2 infection among frontline police personnel in Mumbai, India |
Shibal Bhartiya, Babasaheb V Tandale, Shailesh D Pawar, Nishant Kumar |
| 33 |
[GO] |
2022―Apr―06 |
Respiratory viral infections other than SARS CoV-2 among the North Indian patients presenting with acute respiratory illness during the first COVID-19 wave |
Monika Sapra, Sangeetha Kirubanandhan, Poonam Kanta, Arnab Ghosh, Kapil Goyal, Mini P. Singh, R. K. Ratho |
| 34 |
[GO] |
2022―Feb―01 |
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges |
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, Asma Talukder |
| 35 |
[GO] |
2022―Jan―21 |
Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target |
Hicham Charoute, Zouhair Elkarhat, Lamiae Elkhattabi, Elmostafa El Fahime, Naoual Oukkache, Hassan Rouba, Abdelhamid Barakat |
| 36 |
[GO] |
2021―Nov―05 |
Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2 |
Debadrita Paul, Nibedita Pyne, Santanu Paul |
| 37 |
[GO] |
2021―Oct―25 |
MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses |
Mahdiyar Iravani Saadi, Mani Ramzi, Zahra Hesami, Nadiya kheradmand, Maryam Owjfard, Ehsan Nabi Abdolyousefi, Zahed Karimi |
| 38 |
[GO] |
2021―Sep―24 |
Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy |
Mukul Kumar Singh, Mayank Jain, Hari Shyam, Pratap Shankar, Vishwajeet Singh |
| 39 |
[GO] |
2021―Sep―21 |
Correction to: Do inflammasome impact COVID-19 severity? |
Maria Beatriz Calado, Crislayne Emilly da Silva Santana, Sergio Crovella |
| 40 |
[GO] |
2021―Sep―20 |
Prospective evaluation of specimen pooling strategy for detection of SARS-CoV-2 using pools of five and six specimens |
Georgios Meletis, Styliani Pappa, Maria Exindari, Georgia Gioula, Evangelia Giosi, Antonios Katsoulas, Ilias Mavrovouniotis, Anna Papa |
| 41 |
[GO] |
2021―Sep―07 |
Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes |
Aditya Agrawal, Rajat Varshney, Mamta Pathak, Shailesh Kumar Patel, Vishal Rai, Sourabh Sulabh, Rohini Gupta, Khushal Singh Solanki, Ritu Varshney, Ramadevi Nimmanapalli |
| 42 |
[GO] |
2021―Aug―18 |
Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study |
Jafar Roshandel, Sam Alahyari, Mehdi Khazaei, Reyhane Asgari, Yashar Moharamzad, Ehsan Zarei, Morteza Sanei Taheri |
| 43 |
[GO] |
2021―Jul―31 |
Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach |
D. R. Sherin, N. Sharanya, T. K. Manojkumar |
| 44 |
[GO] |
2021―Jul―26 |
Dentistry pathways of coronaviruses transmission: a review |
Zahra Setayesh-Mehr, Mahdiye Poorsargol |
| 45 |
[GO] |
2021―Jul―26 |
Do inflammasome impact COVID-19 severity? |
Maria Beatriz Calado, Crislayne Emilly da Silva Santana, Sergio Crovella |
| 46 |
[GO] |
2021―Jul―26 |
Computational Identification of SARS-CoV-2 Inhibitor in Tinospora cordifolia, Cinnamomum zeylanicum and Myristica fragrans |
Viswajit Mulpuru, Nidhi Mishra |
| 47 |
[GO] |
2021―Jul―22 |
COVID-19 gripped the globe with some unnoticed facts and too many questions |
Awanish Kumar |
| 48 |
[GO] |
2021―Jul―15 |
Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach |
Swetha Pulakuntla, Kiran Bharat Lokhande, Pannuru Padmavathi, Meena Pal, Kakumani Venkateswara Swamy, Jayashree Sadasivam, Shri Abhiav Singh, Sree Latha Aramgam, Vaddi Damodara Reddy |
| 49 |
[GO] |
2021―Jul―15 |
Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2 |
Buddha Bahadur Basnet, Rajesh Basnet, Raju Panday |
| 50 |
[GO] |
2021―Jul―13 |
A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains |
Reza Rahmani, Neda Eivazi, Maliheh Paknejad, Mahdi Aminian |
| 51 |
[GO] |
2021―Jul―01 |
Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (Mpro) |
Misbaudeen Abdul-Hammed, Ibrahim Olaide Adedotun, Victoria Adeola Falade, Adewusi John Adepoju, Sabitu Babatunde Olasupo, Modinat Wuraola Akinboade |
| 52 |
[GO] |
2021―Jun―25 |
Attitude and associated factors of COVID-19 vaccine acceptance among health professionals in Debre Tabor Comprehensive Specialized Hospital, North Central Ethiopia; 2021: cross-sectional study |
Yewlsew Fentie Alle, Keder Essa Oumer |
| 53 |
[GO] |
2021―Jun―24 |
Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view |
Sonali Bhattacharya, Sudipta Majumdar Nee Paul |
| 54 |
[GO] |
2021―Jun―24 |
Why Is Hormone Therapy Successful Strategy Against Coronavirus-19? |
Gholamreza Asadikaram, Mohammad Kazemi Arababadi |
| 55 |
[GO] |
2021―Jun―23 |
In vitro antiviral activities of ethanol and aqueous extracts of Vietnamese traditional medicinal plants against Porcine Epidemic Diarrhea virus: a coronavirus family member |
Thi Bich Ngoc Trinh, Diep Hong Le, Thanh Thi Kim Nguyen, Van Tam Nguyen, Minh Hong Nguyen, Marc Muller, Hai The Pham, Van Phan Le, Thao Kim Nu Nguyen |
| 56 |
[GO] |
2021―Jun―09 |
SARS-Cov2: a meta-analysis of symptom distribution by continent in 7310 adult COVID-19 infected patients |
Hitesh Singhavi, Ameya Pai, Manish Mair, Jinesh Singhavi, Prachi Gandhi, Andrew Baker, Sudip Das, Sanjeev Kumar, Peter Conboy |
| 57 |
[GO] |
2021―Jun―05 |
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s) |
Swaraj Mohanty, Subhojit Paul, Yasmin Ahmad |
| 58 |
[GO] |
2021―Jun―04 |
Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction |
Martin Gnoni, Renato Beas, Raúl Vásquez-Garagatti |
| 59 |
[GO] |
2021―Jun―03 |
Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity |
Swati Srivastava, Iti Garg, Anju A. Hembrom, Bhuvnesh Kumar |
| 60 |
[GO] |
2021―May―25 |
The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship |
Supram Hosuru Subramanya, Daniel M. Czyż, Krishna Prasad Acharya, Hilary Humphreys |
| 61 |
[GO] |
2021―May―05 |
Exploring status of emergency drugs and vaccine development in Covid-19 pandemic: an update |
Alok Sharma, Suhail Ahmed, Jasleen Kaur, Rakesh Chawla, Chandrababu Rejeeth |
| 62 |
[GO] |
2021―May―04 |
Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection |
Utkarsha Sahu, Debasis Biswas, Anirudh Kumar Singh, Prashant Khare |
| 63 |
[GO] |
2021―May―03 |
Detection of SARS-CoV-2 infection by RT-PCR test: factors influencing interpretation of results |
Kiran Munne, Venkanna Bhanothu, Vikrant Bhor, Vainav Patel, Smita D. Mahale, Shailesh Pande |
| 64 |
[GO] |
2021―Apr―29 |
Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors |
Mahmoud Hamed, Mahmoud El-Hasab, Fotouh R. Mansour |
| 65 |
[GO] |
2021―Apr―29 |
A new emerging pandemic of severe fever with thrombocytopenia syndrome (SFTS) |
Divya Sharma, Mohit Kamthania |
| 66 |
[GO] |
2021―Apr―22 |
SARS-CoV-2 aerosol and droplets: an overview |
Udaykumar Ranga |
| 67 |
[GO] |
2021―Apr―10 |
Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19 |
Peter Ifeoluwa Adegbola, Banjo Semire, Olumide Samuel Fadahunsi, Aanuoluwa Eunice Adegoke |
| 68 |
[GO] |
2021―Apr―07 |
COVID-19 infection in a HIV positive health care worker: first case report from a tertiary care hospital of North India |
Ritin Mohindra, Poonam Kanta, Pradakshana Porchezhian, Kapil Goyal, Vikas Suri, Mini P. Singh, Lakshmi PVM, Ashish Bhalla |
| 69 |
[GO] |
2021―Apr―05 |
In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment |
Sahar Qazi, Kayenat Sheikh, Khalid Raza |
| 70 |
[GO] |
2021―Mar―22 |
Vaccines and drugs under clinical trials for prevention and treatment of COVID-19 |
Umesh C. S. Yadav |
| 71 |
[GO] |
2021―Mar―20 |
Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets |
Sushovan Jena, Punnagai Munusami, Balamurali MM, Kaushik Chanda |
| 72 |
[GO] |
2021―Mar―18 |
A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery |
U. Rutwick Surya, N. Praveen |
| 73 |
[GO] |
2021―Mar―17 |
Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19 |
Vikram Thakur, Radha Kanta Ratho, Jiban Jyoti Panda |
| 74 |
[GO] |
2021―Mar―10 |
Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus |
Ritu Ghildiyal, Reema Gabrani |
| 75 |
[GO] |
2021―Mar―04 |
Evaluation of diagnostic accuracy of developed rapid SARS-COV-2 IgG antibody test kit using novel diluent system |
Vani Maya, Jyothi Embekkat Kaviyil, Dinoop Koral Ponnambath, Renjith P. Nair, Anugya Bhatt, Rajendra Pilankatta, Lathika Valliyot, Ranjeet Dungdung, Ramdas Athikkal Veettil, Manoj Gopi |
| 76 |
[GO] |
2021―Feb―22 |
SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology |
Amit Kumar Sahu, M. Sreepadmanabh, Mahendra Rai, Ajit Chande |
| 77 |
[GO] |
2021―Feb―18 |
Cognitive assessment in asymptomatic COVID-19 subjects |
Sridhar Amalakanti, Kesava Venkata Raman Arepalli, Jyothi Priya Jillella |
| 78 |
[GO] |
2021―Jan―28 |
In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19 |
Vipul Kumar, Sudhakar Kancharla, Manoj Kumar Jena |
| 79 |
[GO] |
2020―Dec―07 |
Molecular characterisation of porcine reproductive and respiratory syndrome virus from pigs in Kerala |
G. Chaithra, Chintu Ravishankar, Stephy Rose Sebastian, R. Rajasekhar, R. Anoopraj, Binu K. Mani, K. Sumod, Chandankar Vaidehi Deorao, G. Logeshwaran, D. Nandhakumar, Koshy John |
| 80 |
[GO] |
2020―Dec―05 |
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein |
Shailendra K. Saxena, Swatantra Kumar, Preeti Baxi, Nishant Srivastava, Bipin Puri, R. K. Ratho |
| 81 |
[GO] |
2020―Dec―02 |
Selection of animal models for COVID-19 research |
Suresh Kumar, Pardeep Kumar Yadav, Ramesh Srinivasan, Nagarajan Perumal |
| 82 |
[GO] |
2020―Nov―11 |
Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters |
Nabanita Roy Chattopadhyay, Koustav Chatterjee, Antara Banerjee, Tathagata Choudhuri |
| 83 |
[GO] |
2020―Nov―11 |
Structure-guided discovery approach identifies potential lead compounds targeting Mpro of SARS-CoV-2 |
Mohcine Elmessaoudi-Idrissi, Kyoko Tsukiyama-Kohara, Jalal Nourlil, Anass Kettani, Marc P. Windisch, Michinori Kohara, Yashpal Singh Malik, Kuldeep Dhama, Soumaya Benjelloun, Sayeh Ezzikouri |
| 84 |
[GO] |
2020―Oct―16 |
SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations |
Sarayu Krishnamoorthy, Basudev Swain, R. S. Verma, Sachin S. Gunthe |
| 85 |
[GO] |
2020―Oct―16 |
2019-nCoV: a worldwide concern and facts |
Rajani Sharma, Gargi Akhoury |
| 86 |
[GO] |
2020―Sep―11 |
SARS-CoV-2 infection: physiological and environmental gift factors at high altitude |
Swati Srivastava, Iti Garg, Anju Bansal, Bhuvnesh Kumar |
| 87 |
[GO] |
2020―Aug―08 |
Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India |
Senthilkumar Natesan, Ragini Bhatia, Aarthi Sundararajan, Kuldeep Dhama, Yashpal S. Malik, Kranti Vora |
| 88 |
[GO] |
2020―Jun―26 |
The global emergence of severe acute respiratory syndrome coronavirus 2 in human |
Bikash Mandal |
| 89 |
[GO] |
2020―Jun―23 |
Emerging coronavirus diseases and future perspectives |
Shireen Akhter, Shahzeen Akhtar |
| 90 |
[GO] |
2020―Jun―22 |
Decoding the global outbreak of COVID-19: the nature is behind the scene |
Piyanki Das, Tathagata Choudhuri |
| 91 |
[GO] |
2020―Jun―13 |
COVID-19 diagnostic approaches: different roads to the same destination |
Ramesh Kumar, Suman Nagpal, Samander Kaushik, Sanjay Mendiratta |
| 92 |
[GO] |
2020―Jun―11 |
Relevance of SARS-CoV-2 in food safety and food hygiene: potential preventive measures, suggestions and nanotechnological approaches |
Zafer Ceylan, Raciye Meral, Turgay Cetinkaya |
| 93 |
[GO] |
2020―Jun―11 |
Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era |
Dinesh Kumar Rajendran, Varthini Rajagopal, S. Alagumanian, T. Santhosh Kumar, S. P. Sathiya Prabhakaran, Dharun Kasilingam |
| 94 |
[GO] |
2020―Jun―10 |
Statistical analysis and visualization of the potential cases of pandemic coronavirus |
R. Muthusami, K. Saritha |
| 95 |
[GO] |
2020―Jun―05 |
Inanimate surfaces as potential source of 2019-nCoV spread and their disinfection with biocidal agents |
Muhammad Zeeshan Akram |
| 96 |
[GO] |
2020―May―24 |
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor |
Vimal K. Maurya, Swatantra Kumar, Anil K. Prasad, Madan L. B. Bhatt, Shailendra K. Saxena |
| 97 |
[GO] |
2020―May―22 |
What we know about 2019-nCoV in Iran in the early stage? |
Milad Dodangeh, Masoud Dodangeh, Mohammadamin Joulani, Azinmehr Elahian Boroujeni |
| 98 |
[GO] |
2020―May―12 |
Human coronaviruses with emphasis on the COVID-19 outbreak |
Saraj Bahadur, Wenxing Long, Muhammad Shuaib |
| 99 |
[GO] |
2020―May―06 |
The dipeptidyl peptidase-4 expression in some MERS-CoV naturally infected dromedary camels in Saudi Arabia 2018-2019 |
Abdelmohsen Alnaeem, Samy Kasem, Ibrahim Qasim, Ali Al-Doweriej, Mohamed Refaat, Abdulkareem Al-Shabebi, Maged Gomaa Hemida |
| 100 |
[GO] |
2020―May―04 |
The Indian perspective of COVID-19 outbreak |
Samander Kaushik, Sulochana Kaushik, Yashika Sharma, Ramesh Kumar, Jaya Parkash Yadav |
| 101 |
[GO] |
2020―May―04 |
The molecular biology of intracellular events during Coronavirus infection cycle |
Juhi Jain, Sharad Gaur, Yash Chaudhary, Rajeev Kaul |
| 102 |
[GO] |
2020―May―02 |
Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock |
Dipti Mothay, K. V. Ramesh |
| 103 |
[GO] |
2020―Apr―20 |
One month of the novel coronavirus 2019 outbreak: Is it still a threat? |
Apu Chowdhury, Nabila Jahan, Sicen Wang |
| 104 |
[GO] |
2020―Apr―20 |
Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives |
Khadga Raj, Anirban Ghosh, Shamsher Singh |
| 105 |
[GO] |
2020―Apr―20 |
Coronavirus threat to Indian population: risk factors, transmission dynamics and preparedness to prevent the spread of the virus |
Dibyakanti Mandal |
| 106 |
[GO] |
2020―Apr―18 |
Recent apprise on coronavirus and its terrible insinuations |
Sankha Bhattacharya, Priyanka Sharma, Harshita Mathur, Haamid Rasheed, Saranjit Singh, Geeta Rajput, Suyash Agnihotri, Puneet Nirmal, Sukhbir Kaur |
| 107 |
[GO] |
2020―Apr―08 |
Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020 |
Arshi Islam, Anwar Ahmed, Irshad H. Naqvi, Shama Parveen |
| 108 |
[GO] |
2020―Mar―05 |
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) |
Swatantra Kumar, Vimal K. Maurya, Anil K. Prasad, Madan L. B. Bhatt, Shailendra K. Saxena |
